menu
    • menu

    Company profile for Oxygenta Pharmaceutical

    Virupaksha-PSE
    News
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    Amgen's Rare Disease Drug Linked to Deaths with- liver injuries

    16 May 2026

    // REUTERS

    Candel Reports Long-Term Prostate Cancer Data Ahead of FDA Filing

    16 May 2026

    // ENDPOINTS

    DATA COMPILATION
    #PharmaFlow

    Read More

    Contact Supplier

    Website

    PEGS Boston Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued

    EVENTS

    DIGITAL CONTENT

    INTERMEDIATES

    PharmaCompass

    Oxygenta Pharmaceutical Limited — Powering healthcare through reliable pharmaceuticals and organic fine chemicals

    Related CompaniesRelated Companies

    About

    Oxygenta Pharmaceutical Limited was incorporated as a private limited company in 1990 and later converted into a limited company in 1993. The company was established with the objective of manufacturing and supplying a wide range of pharmaceutical products. Our expertise includes producing all classes and kinds of drugs, pharmaceutical formulations, and organic fine chemicals. We are committed to providing high-quality, safe, and effective healthcare solutions while adhering to industry standards and regulatory requirements.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oxygenta Pharmaceuticalindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Survey No. 252/1, Aroor(V), Sadasivapet(M), Sangareddy (Dist) - 502291 Telanga...
    Telephone
    Telephone
    08455 250080
    Client Email
    Email
    info@oxygentapharma.com
    Client Website
    Website
    http://oxygentapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    https://www.bseindia.com/xml-data/corpfiling/AttachHis/1C45CF51-65B3-4DE7-B64C-CE5E996BBAD7-191527.pdf

    BSEINDIA
    30 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search